Literature DB >> 13917379

Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin.

J STOKES, M R HILLEMAN, R E WEIBEL, E B BUYNAK, R HALENDA.   

Abstract

Entities:  

Keywords:  GAMMA GLOBULIN; MEASLES/immunology

Mesh：

Substances：

Year:  1962        PMID： 13917379     DOI： 10.1056/NEJM196208022670503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  VACCINATION OF INFANTS WITH LIVING ATTENUATED MEASLES VACCINE (EDMONSTON STRAIN) WITH AND WITHOUT GAMMA-GLOBULIN.

Authors:  P F BENSON; N R BUTLER; A P GOFFE; G J KNIGHT; G D LAURENCE; C L MILLER; T M POLLOCK
Journal:  Br Med J       Date:  1964-10-03

2.  MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.

Authors:  E NORRBY; R LAGERCRANTZ; S GARD
Journal:  Br Med J       Date:  1965-03-27

3.  INACTIVATED MEASLES-VIRUS VACCINE.

Authors:  W H FOEGE; O S LELAND; C S MOLLOHAN; V A FULGINITI; D A HENDERSON; C H KEMPE
Journal:  Public Health Rep       Date:  1965-01       Impact factor: 2.792

4.  METHODS OF DETERMINING IMMUNITY, DURATION AND CHARACTER OF IMMUNITY RESULTING FROM MEASLES.

Authors:  G ENDERS-RUCKLE
Journal:  Arch Gesamte Virusforsch       Date:  1965

5.  A FOLLOW-UP STUDY OF IMMUNITY IN CHILDREN VACCINATED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.

Authors:  P HALONEN; P FORSSELL; A BACKMAN
Journal:  Arch Gesamte Virusforsch       Date:  1965

6.  Infectious Diseases: Annual Review of Significant Publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1963-08       Impact factor: 2.401

7.  Rubella antibody levels in commercial gamma globulin preparations.

Authors:  S J Millian; A Kogon; S Klein
Journal:  Am J Public Health       Date:  1971-02       Impact factor: 9.308

8.  RESPONSE OF VOLTA CHILDREN TO LIVE ATTENUATED MEASLES VIRUS VACCINE.

Authors:  H M MEYER; D D HOSTETLER; B C BERNHEIM; N G ROGERS; P LAMBIN; A CHASSARY; J E SMADEL
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

9.  The repeated setbacks of HIV vaccine development laid the groundwork for SARS-CoV-2 vaccines.

Authors:  Jeffrey E Harris
Journal:  Health Policy Technol       Date:  2022-03-21       Impact factor: 5.211
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.